Showing results (51-60 of 159) with videos related to

Sort By:
Pageof 16
Open Forum Infectious Diseases|July 15, 2021
Cefiderocol Activity Against Clinical <i>Pseudomonas aeruginosa</i> Isolates Exhibiting Ceftolozane-Tazobactam ResistancePatricia J Simner, Stephan Beisken, Yehudit Bergman, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2023
Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use ProgramMichael J Satlin, Patricia J Simner, Christine M Slover, et al.
Journal of Clinical Microbiology|March 8, 2019
A Novel Phenotypic Method To Screen for Plasmid-Mediated Colistin Resistance among <i>Enterobacteriales</i>Drew T Bell, Yehudit Bergman, Abida Q Kazmi, et al.
Journal of Clinical Microbiology|September 17, 2020
Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-Negative Bacilli: a Comparison of Disk Diffusion to Broth MicrodilutionC Paul Morris, Yehudit Bergman, Tsigedera Tekle, et al.
Journal of Clinical Microbiology|April 8, 2016
Evaluation of Multiple Methods for Detection of Gastrointestinal Colonization of Carbapenem-Resistant Organisms from Rectal SwabsPatricia J Simner, Isabella Martin, Belita Opene, et al.
Indian Journal of Medical Microbiology|February 14, 2026
Plazomicin Activity against Carbapenem-Resistant Escherichia coli: A Brief ReportPriti Kambli, Shaoli Basu, Susan Rodrigues, et al.
Journal of Clinical Medicine|June 27, 2024
No Evidence of Chronic Infection in a Metagenomic Sequencing Study of the Keratoconus Corneal EpitheliumPritpal Kaur, Loren Moon, Divya Srikumaran, et al.
The Journal of Antimicrobial Chemotherapy|October 23, 2024
Differential frequency of persister cells in clinically derived isolates of Pseudomonas aeruginosa after exposure to cefiderocol and ceftolozane/tazobactamAliaa Fouad, Samantha E Nicolau, Pranita D Tamma, et al.
Pageof 16